There are numerous lawsuits from people against companies, blaming their GLP-1s for health complications like serious stomach problems and alleging that they werent properly warned of potential risks
Similarly, tirzepatide (Zepbound) demonstrated up to 22.5% weight loss in a 72-week trial with the same approach
By 52 weeks, 81% of those on Wegovy had returned to normal blood sugar levels (normoglycaemia), compared with 14% on placebo
Acetic acid slows stomach emptying, prolongs satisfaction, and triggers a modest rise in native GLP-1, which can curb casual snacking without shutting down hunger entirely
Chan YW, Van den Berg HA, Moore JD, Quenby S, Blanks AM